News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

An Opportunity to Strengthen Key Health Measures in National Climate Plans

woman holding poster saying climate emergency equals health emergency

The majority of national climate adaptation plans fail to fully integrate health needs or engage populations most at risk from climate change, found an international team of investigators led by Weill Cornell Medicine.

The study was published on June 10 in Lancet Planetary Health. Senior author Dr. Ilan Cerna-Turoff, assistant professor of epidemiology in emergency medicine at Weill Cornell Medicine, and his study team reviewed climate adaptation policies from 198 countries and the European Union, finding that while 88% mentioned the health impacts of climate change, important gaps in health integration remain. Progress on health integration was variable, with several regions of the world falling behind. Some health conditions were nearly absent. Despite the widespread recognition that specific demographic groups were disproportionately affected by the health impacts of climate change, only 12% of the plans engaged these groups in their efforts. Many plans also lacked sufficient budgeting for monitoring and evaluation and health-related climate actions.

Innovators Pitch Cell Therapies and AI Tools at Biomedical Innovation Challenge

Six people (four men and two women) wearing business attire in a group photo

The eighth cohort of the Biomedical Innovation Challenge showcased its innovations and development plans during a lightning round of pitches and judges’ questions on June 4 in the Belfer Research Building.

The annual event serves as the culmination of BioVenture eLab’s entrepreneurial education program for Weill Cornell faculty and trainees who aspired to take the next step in translating their discoveries into fundable early-stage innovation projects. This year, five teams presented their innovations, as well as their plans to navigate the commercialization journeys ahead to catalyze their research into products aimed at changing patients’ lives.

“Innovation doesn't happen unless scientists and clinicians are willing to learn something new, to think differently and to pursue solutions beyond the current standard of care,” said Loren Busby, director of BioVenture eLab, noting how this latest class had evolved from researchers into entrepreneurs after completing the program. “This is the definition of entrepreneurship on which we rely in our program.”

Brain Region Linked to TMS’s Antidepressant Effects

drawing of brain with insular cortex in orange

A circuit that runs from the prefrontal cortex near the front of the brain to a deeper brain structure called the insular cortex appears to mediate the antidepressant effects of a newer form of transcranial magnetic stimulation (TMS), according to a study led by Weill Cornell Medicine investigators. The discovery could lead to more effective TMS treatment of depression.

In the study, published May 7 in Cell, the researchers developed mice whose brains can be stimulated artificially in a prefrontal region to mimic the antidepressant effect of a widely used—but not well understood—TMS technique. The researchers showed that this antidepressant effect in the mice depends heavily on the indirect stimulation of a connected region, the insular cortex.